Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDIT Net Margin

The Net Margin of Medite Cancer Diagnostics Inc (MDIT) is -99.97%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

MDIT Net Margin - Historical Value
Date Value
2017-12-31 -99.97%
2016-12-31 -23.41%
2015-12-31 -8.69%
2014-12-31 -6.36%
2013-12-31 0.54%
2012-12-31 -764.65%
2011-12-31 -14400.00%
2010-12-31 -7000.00%
2009-12-31 -8875.00%
2008-12-31 -4869.23%
MDIT Net Margin - Peers Comparison